<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The objective was designed to assess the clinical efficiency of preventing febrile nonhemolytic transfusion reactions (FNHTR) with transfusion of leukocyte-depleted RBC and platelet concentrates </plain></SENT>
<SENT sid="1" pm="."><plain>One hundred patients with <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> of liver, <z:hpo ids='HP_0002592'>gastric ulcer</z:hpo> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> were selected to receive RBC concentrates with leukocyte filtration </plain></SENT>
<SENT sid="2" pm="."><plain>Another group of 50 patients with <z:mp ids='MP_0001654'>liver necrosis</z:mp>, <z:hpo ids='HP_0002592'>gastric ulcer</z:hpo> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> were selected to receive non-filtered RBC concentrates </plain></SENT>
<SENT sid="3" pm="."><plain>Two hundred and forty patients with <z:hpo ids='HP_0011009'>acute</z:hpo> or <z:hpo ids='HP_0005558'>chronic leukemia</z:hpo>, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> <z:hpo ids='HP_0000979'>purpura</z:hpo>, <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> of liver, upper <z:hpo ids='HP_0002239'>gastrointestinal hemorrhage</z:hpo>, severe <z:hpo ids='HP_0012115'>hepatitis</z:hpo>, burn and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> post radioactive or chemical treatment were divided into two group with 120 patients in each one and selected randomly to receive platelet concentrates </plain></SENT>
<SENT sid="4" pm="."><plain>The incidence rates of FNHTR in <z:hpo ids='HP_0000001'>all</z:hpo> patients were investigated </plain></SENT>
<SENT sid="5" pm="."><plain>Results showed that there was no FNHTR in 100 transfusions with leukocyte-depleted RBC concentrates </plain></SENT>
<SENT sid="6" pm="."><plain>Eight out of 50 patients with non-filtrated RBC concentrates showed FNHTR </plain></SENT>
<SENT sid="7" pm="."><plain>The incidence of FNHTR was sixteen (16%) in non-filtrated transfusion </plain></SENT>
<SENT sid="8" pm="."><plain>Twenty-five and 7 patients manifested FNHTR respectively in non-filtrated or filtrated platelets transfusions </plain></SENT>
<SENT sid="9" pm="."><plain>The incidence of FNHTR was 20.83% and 5.83% respectively in non-filtrated or filtrated platelet transfusion </plain></SENT>
<SENT sid="10" pm="."><plain>It is concluded that leukocyte-depleted RBC and platelet concentrates reduces FNH TR in blood transfusion </plain></SENT>
</text></document>